Table 2.
Depression screening and depression outcome variables at BL, 4, 8, 12, and 24 weeks
| BL | 4 weeks | 8 weeks | 12 weeks | 24 weeks | P value* | |
|---|---|---|---|---|---|---|
| BDI-II | ||||||
| Total group | 20.7±7.5 (74) | |||||
| CBT only | 20.6±9.4 (19) | |||||
| EX only | 19.5±4.8 (20) | |||||
| UC | 20.7±7.5 (17) | |||||
| CBT/EX | 22.0±8.5 (18) | |||||
| HAM-D | ||||||
| Total group | 15.9±4.3 (74) | 10.85±5.3 (73) | 7.9±5.1 (67) | 8.3±5.2 (66) | 7.4±5.1 (62) | NS |
| CBT only | 15.9±4.9 (19) | 11.3±3.9 (19) | 6.9±4.9 (18) | 8.2±6.3 (17) | 7.1±4.9 (16) | NS |
| EX only | 15.4±3.4 (20) | 10.4±3.9 (20) | 9.8±5.7 (18) | 8.4±5.6 (18) | 8.3±5.2 (17) | NS |
| UC | 15.2±3.6 (17) | 13.8±5.2 (17) | 11.0±4.9 (15) | 9.3±4.9 (15) | 8.2±5.4 (14) | NS |
| CBT/EX | 17.1±4.3 (18) | 10.8±5.8 (17) | 7.4±4.7 (16) | 6.5±3.7 (16) | 6.1±5.1 (15) | NS |
*
P values reflect RMANOVA across all time points controlling for age, gender, NYHA class, and antidepressant use.